Raise Your Voice for Meningococcal Disease Vaccination

Raise Your Voice for Meningococcal Disease Vaccination

MKT19193

Slide 2

Welcome

[NAME]

[TITLE]

[National Association of School Nurses Affiliate]

Slide 3

Clinical Overview: Meningococcal Disease

• Infection caused by the bacterium Neisseria meningitidis1

—Serotypes A, B, C, Y, and W-135 cause majority of meningococcal disease cases worldwide2

—Leading cause of bacterial meningitis among US toddlers, children and adolescents

• Serotypes B, C, and Y most common in US2

• Meningococcal disease can cause meningitis (swelling of the brain or spinal cord) or meningococcemia (blood infection)3

• Vaccination is safe and effective and the best way to help prevent the disease among adolescents3

References:1. Centers for Disease Control and Prevention (CDC). Meningococcal disease – New England, 1993 – 1998. MMWR. 1999;48(29):629-633. 2. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. 10th ed. Washington, D.C.: Public Health Foundation, 2008. 3. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010.

Slide 4

• Approximately 1000 to 2600 Americans get meningococcal disease annually1

— The disease rates peak at 15-19 years of age2

• When meningococcal disease occurs the consequences can be devastating1

— Fast progressing…can take a life in just a single day3

— Teens are up to 5 times more likely to die than other age groups2

— Among survivors, 1 in 5 will suffer permanent complications• Amputation, hearing loss, neurological damage, and organ failure1,4

• Early symptoms can resemble the flu, making diagnosis difficult— Symptoms include fever, headache, stiff neck, nausea and vomiting,

and rash5-6


References:1. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010. 2. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286:695-699. 3. Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33:737-739. 4. National Meningitis Association. Overview. http://www.nmaus.org/meningitis. Accessed April 7, 2010. 5. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th edition. Philadelphia, Pa: Elsevier Inc; 2008:399-435. 6. National Meningitis Association. Symptoms. http://www.nmaus.org/meningitis/symptoms.htm. Accessed April 7, 2010.

Slide 5


• Spread from person to person through close, personal contact and exchange of respiratory secretions1

• Common everyday activities can put adolescents at increased risk for infection; these activities or risks include:1-2

— Sharing drinking glasses and eating utensils

— Kissing

— Living in close quarters

— Smoking (or being exposed to smoke)

• Meningococcal disease can occur at any point during the year — Late-winter and early-spring are when most cases occur3

References:1. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th edition. Philadelphia, Pa: Elsevier Inc; 2008:399-435. 2. National Meningitis Association. Who is at risk. http://www.nmaus.org/meningitis/who-is-at-risk.htm. April 7, 2010. 3. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. 10th ed. Washington, D.C.: Public Health Foundation, 2008.

Slide 6


• Once diagnosed with meningococcal disease, early antibiotic treatment is critical1

—Even with treatment, meningococcal disease can kill an otherwise healthy young person1-2

• Close contacts should also receive preventive antibiotics1

—Family members, close friends

References:1. Rosenstein NE, et al. Meningococcal disease. N Engl J Med. 2001;344(18):1378. 2. Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33:737-739.

Slide 7

Vaccination – The Best Protection

• Vaccination continues to be the best way to prevent meningococcal disease—Helps protect against 4 of the 5 primary serotypes (A, C, Y, and W-

135)1

• Centers for Disease Control and Prevention (CDC) recommends routine vaccination for:2-3

—Adolescents 11-18 years of age—College freshmen living in dormitories—Children 2 through 10 years of age at increased risk—Anyone 2 through 10 years of age if elected by parent or health-care

provider

References:1. CDC. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed April 7, 2010. 2. CDC. Notice to readers: revised recommendations of the ACIP to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR. 2007;56(31):794-795. 3. CDC. Notice to readers: recommendation from the ACIP for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease. MMWR. 2007;56(48):1265-1266.

Slide 8

Vaccination Rates Alarmingly Low

• In 2008, only 41.8% of teens 13-17 years of age received the recommended meningococcal vaccine1 —Far from the CDC’s goal of a 90% immunization rate2

• Florida has a 33.6% rate of meningococcal vaccination among adolescents 13-17 years of age

References:1. CDC. National Immunization Survey (NIS) adolescents/teens only: coverage with Individual vaccines. http://www.cdc.gov/vaccines/stats-surv/nisteen/tables/08/tab01_iap.xls. Accessed

April 7, 2010. 2. CDC. National, state, and local area vaccination coverage among adolescents aged 13-17 Years - United States, 2008. MMWR. 2009;58(36);997-1001.

Slide 9

Why Aren’t More Teens Getting Vaccinated?1-3

• Many parents and students still unaware of disease, vaccine

• Fewer health maintenance visits

• Missed immunization opportunities

• Lack of population-based immunization registries that include adolescents

• Low public awareness about adolescent immunization coverage, recommendations, and available vaccinations

• Misperceptions about vaccine safety

References:1. National Foundation for Infectious Diseases (NFID). Meningococcal vaccination: improving rates in adolescents and reducing racial, ethnic and socioeconomic disparities, 2008. http://stopmeningitis.nfidinitiatives.org/pdf/CTA.pdf. Accessed April 7, 2010. 2. Oster NV, et al. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005;18(1):13. 3. Freed GL, Clark SJ, Butchart AT. Parental vaccine safety concerns in 2009. Pediatrics. 2010;10:654-659.

Slide 10

Vaccination Requirements in Elementary and Secondary Schools1-4

References:1. Immunization Action Coalition. Meningococcal state mandates for elementary and secondary schools. http://www.immunize.org/laws/menin_sec.asp. Accessed April 7, 2010. 2. New York State Department of Health. New York recommended childhood and adolescent immunization schedule. http://www.health.state.ny.us/publications/2378.pdf. Accessed April 7, 2010. 3. Indiana State Department of Health. 2010-2011 school year Indiana State Department of Health (ISDH) school immunization requirements quick reference guide. http://www.hse.k12.in.us/PDF/clinicalServices/Immunization%20Chart.pdf. Accessed April 7, 2010. 4. Michigan Department of Community Health. New communicable disease rules 2010-2011 school reporting year. http://www.swartzcreek.org/Pupil/SS_NewSchReqmnts1-10.pdf. Accessed April 7, 2010. 5. State of California Legislative Counsel. California Health and Safety Code. http://www.leginfo.ca.gov/cgi-bin/waisgate?WAISdocID=26994629975+0+0+0&WAISaction=retrieve. Accessed May 7, 2010.

States requiring vaccinationStates requiring education

Slide 11

School Nurses: Helping to Prevent Meningococcal Disease

• School nurses play an instrumental role in raising awareness about meningococcal disease and vaccination—Leading advocate in adolescent health —Direct reach to adolescents, parents, and families—Trusted source of health information

• Parents rely on school nurses for information surrounding the health and well-being of their children

Slide 12

• Become a “Voice” of Meningitis

• A public awareness campaign by the National Association of School Nurses (NASN) in collaboration with sanofi pasteur—Gives “voice” to meningitis through sharing stories of those

personally affected by the disease

• Parents

• Disease survivors

• School nurses

How You Can Help Support Educational Efforts in Florida

Slide 13

Voices of Meningitis Objectives

• Empower school nurses to further educate parents, teens—Parents rely on school nurses for health information

• Educate parents and teens about dangers of meningococcal disease, encourage them to seek vaccination

• Encourage dialog between parents, school nurses, and other health-care providers about meningococcal vaccination

Slide 14

Voices of Meningitis Challenge

• “Challenges” school nurses to implement meningococcal educational efforts

• Provides school nurses with resources and strategies

• Recognizes school nurses for their educational efforts—Highlights successes in raising awareness of

meningococcal disease and prevention

• Fosters sharing of ideas and strategies nationwide

Slide 15


• Challenge “Champions” to offer guidance and support

Great Plains

Mid-Atlantic

Midwest

New England

South

Southeast

Southwest

West

West RegionChampion: Cheryl Sampson;

[email protected]

Great Plains RegionChampion: Carol Tucker;

[email protected] and Polly Witt;

[email protected]

Midwest RegionChampion: Cindy Hiltz;

[email protected]

New England RegionChampion: Linda Twardowski;

[email protected]

Southwest RegionChampion: Linda Hummingbird;[email protected]

Mid-Atlantic RegionChampion: Beth Mattey;

[email protected]

Southeast RegionChampion: Jennifer Garrett;

[email protected] and

Kathleen Rose; [email protected]

South RegionChampion: Mary Glasscock;

[email protected], andShawn Smith;

[email protected]; and Michelle Keith;

[email protected]

mailto:[email protected]

Slide 16


• Implementation Guide—Provides ideas to initiate meningococcal disease awareness

programming within communities

• Educational materials —Posters—Brochure—Fact sheet—Report card sticker—Parent letters —Media materials—Educational videos

• Complimentary materials available on VoicesOfMeningitis.org

Slide 17


• Submit case studies of all awareness activities conducted— Case studies featured on the National Association of School Nurses

(NASN) Web site

— Serves as repository of ideas and strategies for school nurses nationwide

• Five case studies selected to be presented during the 2011 NASN Annual Conference

• Online submission form on NASN Web site

Slide 18

Tips to Use Online Resources

• Parent Mailings and Report Cards —Send a Voices of Meningitis brochure or letter home to your

students’ parents

• School Assembly—Discuss meningitis during a school assembly or pep rally—Show a Voices of Meningitis educational video

• Local Parent Teacher Association or Organization Partnership—Host a presentation during a regular scheduled meeting; distribute

materials

• Athletic Department Partnership—Involve athletic directors to distribute Voices of Meningitis fact sheets

with sports physical forms

Slide 19

• Happy (and Healthy) Graduation—Send information home with order forms for yearbooks, class

rings, cap and gown, etc.—Set up a table at college fairs

• Online vehicles—Distribute a note about meningitis vaccination via your school’s

parent listserv—Use the Voices of Meningitis widget to link your school’s Web site

with the campaign site

• Visit VoicesOfMeningitis.org

—Includes more information and ideas

Tips to Use Online Resources (con’t)

Slide 20

Questions?

Documents

Raise Your Voice for Meningococcal Disease Vaccination